Skip to main content
SpringerLink
Log in

Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia

  • Letter to the editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bloomfield CD, Lawrence D, Byrd JC, et al. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Res. 1998;58:4173–4179.

    CAS  PubMed  Google Scholar 

  2. Byrd JC, Dodge RK, Carroll A, et al. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol. 1999;17:3767–3675.

    CAS  PubMed  Google Scholar 

  3. Byrd JC, Ruppert AS, Mrozek K, et al. Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461. J Clin Oncol. 2004;22:1087–1094.

    Article  CAS  PubMed  Google Scholar 

  4. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML trial. Blood. 1998;92: 2322–2333.

    CAS  PubMed  Google Scholar 

  5. Usui N, Dobashi N, Kobayashi T, et al. Role of daunorubicin in the induction therapy for adult acute myeloid leukemia. J Clin Oncol. 1998;16:2086–2092.

    CAS  PubMed  Google Scholar 

  6. Usui N, Dobashi N, Asai O, et al. Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute myeloid leukemia. Int J Hematol. 2002;76: 436–445.

    Article  CAS  PubMed  Google Scholar 

  7. Schlenk RF, Benner A, Krauter J, et al. Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia Intergroup. J Clin Oncol. 2004;22:3741–3750.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Oncology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-ku, 105-8461, Tokyo, Japan

    Nobuaki Dobashi, Yuko Yamaguchi, Osamu Asai, Shingo Yano, Hiroshi Osawa, Yuichi Yahagi, Yutaka Takei, Katsuki Sugiyama, Takeshi Saito & Noriko Usui

Authors
  1. Nobuaki Dobashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuko Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Osamu Asai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shingo Yano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroshi Osawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuichi Yahagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yutaka Takei
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katsuki Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Takeshi Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Noriko Usui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nobuaki Dobashi.

About this article

Cite this article

Dobashi, N., Yamaguchi, Y., Asai, O. et al. Intensifying Daunorubicin in Induction for Patients with Core Binding Factor Leukemia. Int J Hematol 84, 463–464 (2006). https://doi.org/10.1532/IJH97.06138

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1532/IJH97.06138

Keywords

Search

Navigation